Literature DB >> 9462707

Mutations in the CDKN2A (p16INK4a) gene in microdissected sporadic primary melanomas.

R Kumar1, B Lundh Rozell, J Louhelainen, K Hemminki.   

Abstract

The role of the CDKN2A (p16INK4a) gene in sporadic primary melanomas has remained unclear due to the inadequate number of mutational studies. In the present study, we analyzed the entire coding region of the CDKN2A gene in microdissected sporadic primary melanomas, for the presence of mutations and polymorphisms, using 2 independent methods of mutation detection, SSCP and CMC. We found 11 intragenic mutations in 8 melanomas out of 31 (26%) and the majority of mutations were located in exon 1, with 2 cases harbouring multiple mutations. Of the mutations detected, 6 were C-to-T transitions, 4 involving CC sites; 2 melanomas showed a novel deletion of one of the two 24-bp repeat units located at the 5' end of exon 1. There was also a high frequency of C-to-G and C-to-T polymorphisms at the nucleotides 540 (frequency of G allele: 0.18) and 580 (frequency of T allele: 0.13) in the 3' untranslated region.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462707     DOI: 10.1002/(sici)1097-0215(19980119)75:2<193::aid-ijc5>3.0.co;2-p

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

Authors:  O Straume; L A Akslen
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

Authors:  P Schraml; K Struckmann; R Bednar; W Fu; T Gasser; K Wilber; J Kononen; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.

Authors:  M Pinyol; L Hernández; A Martínez; F Cobo; S Hernández; S Beà; A López-Guillermo; I Nayach; A Palacín; A Nadal; P L Fernández; E Montserrat; A Cardesa; E Campo
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

4.  Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the upper gastrointestinal tract.

Authors:  Helene Geddert; Sibylle Kiel; Rainer B Zotz; Jianhui Zhang; Reinhart Willers; Helmut E Gabbert; Mario Sarbia
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-15       Impact factor: 4.553

5.  Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase.

Authors:  Oddbjørn Straume; Johanna Smeds; Rajiv Kumar; Kari Hemminki; Lars Andreas Akslen
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

6.  Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells.

Authors:  Ahmad Besaratinia; Sang-In Kim; Gerd P Pfeifer
Journal:  FASEB J       Date:  2008-03-07       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.